You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Ning Cao1, Danielle P Johnson Erickson1, Eric C Ford1
1Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington.
Ultrahigh dose-rate radiation therapy (FLASH) significantly improved survival in preclinical models compared to conventional dose-rate therapy. FLASH spares normal tissues while maintaining tumor control, offering a promising advancement in radiation oncology.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: